FIELD: chemistry.
SUBSTANCE: invention relates to the field of organic chemistry, in particular to a new solid form of the compound of formula (I). The invention also relates to a process for preparing of the said solid forms, pharmaceutical compositions based on the solid form, the use of solid forms of the compound (I) and a method of treating or preventing disorders associated with GABA A α5 receptor.
EFFECT: invention provides obtaining of a new solid form of the compound (I), having improved stability, good bioavailability and low hygroscopic property.
13 cl, 23 dwg, 7 tbl, 28 ex
| Title | Year | Author | Number |
|---|---|---|---|
| TRIAZOLE DERIVATIVES AND APPLICATION THEREOF IN NEUROLOGICAL DISEASES | 2011 |
|
RU2581504C2 |
| APPLICATION OF ACTIVE PHARMACEUTICAL COMPOUNDS FOR TREATMENT OF CENTRAL NERVOUS SYSTEM DISEASES | 2011 |
|
RU2563167C2 |
| ISOXAZOLO-PYRIDINE DERIVATIVES | 2008 |
|
RU2484091C2 |
| NEW CRYSTALLINE MODIFICATION 2-(3, 5-BIS-TRIFLUOROMETHYLPHENYL)-H-[6-(1, 1-DIOXO-1 λ -THIOMORPHOLINE-4-YL)-4-(4-FLUORO-2-MEHTYLPHENYL)PIRIDINE-3-YL]-K-METHYLISOBUTYR AMIDE | 2004 |
|
RU2330022C2 |
| 2-AMINO-PYRIMIDINE DERIVATIVES AS JNK INHIBITORS | 2011 |
|
RU2572247C2 |
| DERIVATIVES OF 1,1-DIOXOTHIOMORPHOLINYLINDOLYL METHANONE FOR USE AS HISTAMINASE MODULATORS | 2006 |
|
RU2412182C2 |
| 1,4 THIAZEPINES/SULPHONES AS BACE1 AND/OR BACE2 INHIBITORS | 2012 |
|
RU2600931C2 |
| TRIAZOLE DERIVATIVES AS GABA RECEPTOR LIGANDS | 2011 |
|
RU2582337C2 |
| DERIVATIVES OF (3-METHYLPYRROLIDIN-3-YL)-METHYL PYRIDINYL ETHER AND THEIR USE AS ANTAGONISTS OF RECEPTOR NK-3 | 2011 |
|
RU2625798C2 |
| CRYSTALLINE TOSYLATE SALT (8S,9R)-5-FLUORO-8-(4-FLUOROPHENYL)-9-(1-METHYL-1H-1,2,4-TRIAZOL-5-YL)-8-9-DIHYDRO-2H-PYRIDO[4,3,2-de]PHTHALAZIN-3(7H)-ONE | 2011 |
|
RU2598606C2 |
